Literature DB >> 19107999

Epigenetics and the nervous system.

Mark F Mehler1.   

Abstract

We are in the midst of a revolution in the genomic sciences that will forever change the way we view biology and medicine, particularly with respect to brain form, function, development, evolution, plasticity, neurological disease pathogenesis and neural regenerative potential. The application of epigenetic principles has already begun to identify and characterize previously unrecognized molecular signatures of disease latency, onset and progression, mechanisms underlying disease pathogenesis, and responses to new and evolving therapeutic modalities. Moreover, epigenomic medicine promises to usher in a new era of neurological therapeutics designed to promote disease prevention and recovery of seemingly lost neurological function via reprogramming of stem cells, redirecting cell fate decisions and dynamically modulating neural network plasticity and connectivity.

Entities:  

Mesh:

Year:  2008        PMID: 19107999     DOI: 10.1002/ana.21595

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  32 in total

Review 1.  IBS: An epigenetic perspective.

Authors:  Timothy G Dinan; John Cryan; Fergus Shanahan; P W Napoleon Keeling; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-29       Impact factor: 46.802

2.  Research in the exercise sciences: where we are and where do we go from here--Part II.

Authors:  Kenneth M Baldwin; Fadia Haddad
Journal:  Exerc Sport Sci Rev       Date:  2010-04       Impact factor: 6.230

Review 3.  Chapter 5. Nuclear actin-related proteins in epigenetic control.

Authors:  Richard B Meagher; Muthugapatti K Kandasamy; Elizabeth C McKinney; Eileen Roy
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

4.  Epigenetic vestiges of early developmental adversity: childhood stress exposure and DNA methylation in adolescence.

Authors:  Marilyn J Essex; W Thomas Boyce; Clyde Hertzman; Lucia L Lam; Jeffrey M Armstrong; Sarah M A Neumann; Michael S Kobor
Journal:  Child Dev       Date:  2011-09-02

5.  ERCC6 dysfunction presenting as progressive neurological decline with brain hypomyelination.

Authors:  Laila Shehata; Dimitre R Simeonov; Anja Raams; Lynne Wolfe; Adeline Vanderver; Xueli Li; Yan Huang; Shannon Garner; Cornelius F Boerkoel; Audrey Thurm; Gail E Herman; Cynthia J Tifft; Miao He; Nicolaas G J Jaspers; William A Gahl
Journal:  Am J Med Genet A       Date:  2014-09-22       Impact factor: 2.802

Review 6.  Gestational hypoxia and epigenetic programming of brain development disorders.

Authors:  Qingyi Ma; Fuxia Xiong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2014-09-26       Impact factor: 7.851

7.  GM1 Ganglioside is Involved in Epigenetic Activation Loci of Neuronal Cells.

Authors:  Yi-Tzang Tsai; Yutaka Itokazu; Robert K Yu
Journal:  Neurochem Res       Date:  2015-10-24       Impact factor: 3.996

Review 8.  Finding a better drug for epilepsy: antiepileptogenesis targets.

Authors:  Katja Kobow; Stéphane Auvin; Frances Jensen; Wolfgang Löscher; Istvan Mody; Heidrun Potschka; David Prince; Alejandra Sierra; Michele Simonato; Asla Pitkänen; Astrid Nehlig; Jong M Rho
Journal:  Epilepsia       Date:  2012-10-12       Impact factor: 5.864

9.  Epigenetics and the nervous system: epiphenomenon or missing piece of the neurotherapeutic puzzle?

Authors:  Rajiv R Ratan
Journal:  Lancet Neurol       Date:  2009-11       Impact factor: 44.182

Review 10.  Molecular basis of the irritable bowel syndrome.

Authors:  Anna Vaiopoulou; Georgios Karamanolis; Theodora Psaltopoulou; George Karatzias; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.